Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on April 1, 2025

WoodWing partners with Open Connections to deliver cutting-edge information management solutions in the UK
LONDON, UNITED KINGDOM, April 1, 2025 /EINPresswire.com/ -- WoodWing today announces a strategic partnership with Open Connections to bring the powerful WoodWing Xtendis information and document management solution to organizations across the UK. Known …

WoodWing en Open Connections bundelen krachten voor leidende informatiemanagement-oplossingen in het Verenigd Koninkrijk
LONDON, UNITED KINGDOM, April 1, 2025 /EINPresswire.com/ -- WoodWing kondigt vandaag een strategische samenwerking aan met Open Connections om haar krachtige informatie management-oplossing WoodWing Xtendis voor informatie- en documentbeheer beschikbaar …

Novel $40K grant to advance celiac, gluten-related disease research
Beyond Celiac and American Gastroenterological Association launch pilot research award PHILADELPHIA, PA, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- Beyond Celiac, the leading nonprofit catalyst for a cure for celiac disease, today announced its …

PNXP Launches Groovy 2.0 Hyperledger Centralized Blockchain Solution
Pinya XP launches centralized blockchain to combat deadly cannabis counterfeits, protect consumers, …

Portsmouth Square Completes Strategic Refinancing of Hilton San Francisco Financial District Hotel
SAN FRANCISCO, CA, April 01, 2025 (GLOBE NEWSWIRE) -- Portsmouth Square, Inc. (OTC: PRSI) ("Portsmouth Square" or "the Company") today announced the successful refinancing of its flagship asset, the Hilton San Francisco Financial District Hotel. This …

Hearing Aids Market projected to surpass US$18.442 billion by 2030 at a CAGR of 7.31%
The hearing aids market is anticipated to grow at a CAGR of 7.31% from US$12.963 billion in 2025 to US$18.442 billion by 2030. NEW YORK, NY, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- According to a new study published by Knowledge Sourcing …

PreVu Launches New Mobile App for Fast Photo-Taking and Instant Upload
Eliminate photography challenges with instant, AI-guided patient photo uploads FT. LAUDERDALE, FL, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- PreVu Software, a leading provider of digital smile simulation technology for dental practices, is …

COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order
TORONTO, ONTARIO, April 01, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a life science company which develops and commercializes a diversified portfolio of cosmeceutical, nutraceutical and …

eLeaP Reinvents Performance Management Platform with Powerful Upgrades
eLeaP relaunches its AI-powered Performance Management Platform, which offers reviews, goal alignment, real-time feedback to boost engagement and productivity. LOUISVILLE, KY, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- eLeaP, a trusted leader in …

Summit Spine Expands with a Unique Physician-Centric Model in Interventional Spine Care
Innovative care model has been the driving force behind the company’s sustained growth over the past ten years. LAWRENCEVILLE, GA, GA, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- Summit Spine …

CodaPet expands compassionate in-home pet euthanasia services in Marietta, GA
The veterinarian-owned startup empowers a network of veterinarians who provide in-home euthanasia to ease the passing of pets at home, surrounded by loved ones. MARIETTA, GA, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- CodaPet has expanded its …

CDC Layoffs Deliver Devastating Blow to Respiratory Health
Washington, DC, April 01, 2025 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) is deeply concerned about recent reductions in force (RIFs) at the Centers for Disease Control and Prevention (CDC), which put critical public health …

HNF-Funded Wearable Sensor Study to Be Presented at the 2025 AAN Annual Meeting
HNF remains dedicated to funding and supporting innovative research efforts that improve the lives of those living with CMT and other neuromuscular disorders. NEW YORK, NY, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- The Hereditary Neuropathy …

Junkosha reveals new look for third Technology Innovator of the Year Award
New early phase development category launched to recognize entries with strong ideas; Junkosha pledges additional $25,000 for new category winner TOKYO, JAPAN, April 1, 2025 /EINPresswire.com/ -- Pioneers of sophisticated fluoropolymer application …

Ida Fanelli Joins the International Order of Fantastic Professionals
EDMONTON, ALBERTA, CANADA, April 1, 2025 /EINPresswire.com/ -- Based in London, Ontario, Canada, Ida Fanelli is a renowned holistic aesthetician, reflexologist, IPL laser technician, and energy healer with over 30 years of experience. Her home-based …

Dr. Sam Speron Launches Laser Hair Cap Pro Therapy to Promote Hair Regrowth
Dr. Sam Speron Launches Laser Hair Cap Pro Therapy to Promote Hair Regrowth CHICAGO, IL, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- Dr. Sam Speron, a board-certified plastic surgeon and founder of Dr. Speron's Natural Skin Care, LLC, is pleased …

Florida Mesothelioma Victims Center Urges a Person Who Had Workplace Exposure to Asbestos in a State Outside of Florida and Now Has Mesothelioma or Lung Cancer to Call the Gori Law Firm-Expect Better Compensation
ORLANDO , FL, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- The Florida Mesothelioma Victims Center is urging the family of an individual who has just discovered they have mesothelioma or lung cancer to please call the Gori Law Firm at 866-532-2106 …

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …

Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis
Target enrollment exceeded with 1009 patients randomized in the main cohort and 410 patients in the exploratory cohort Topline results from NATiV3 projected in the second half of 2026 and, if positive, expected to be the basis for submission for regulatory …

Inventiva annonce la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et de fibrose avancée
Objectifs de recrutement dépassés avec 1.009 patients randomisés dans la cohorte principale et 411 dans la cohorte exploratoire Principaux résultats de NATiV3 attendus au deuxième semestre 2026 et, si positifs, ils supporteront les demandes règlementaires …